Literature DB >> 11054131

Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study.

A Ogunniyi1, O Baiyewu, O Gureje, K S Hall, F Unverzagt, S H Siu, S Gao, M Farlow, O S Oluwole, O Komolafe, H C Hendrie.   

Abstract

We determined the prevalence of dementia in a cohort of 2494 elderly Nigerians residents in Idikan Community, Ibadan, Nigeria. We utilized the Community Screening Instrument for Dementia to select subjects for clinical assessment in the second stage. The findings were compared with those of 2212 African Americans living in Indianapolis, studied simultaneously using similar methodology. The overall age-adjusted prevalence rates of dementia and Alzheimer's disease in Ibadan were 2.29% and 1.41%, respectively. These rates were much lower than the respective values of 8.24% and 6.24% obtained for African Americans. In Ibadan, Alzheimer's disease accounted for 64.3% of the cases, with old age and female gender being the significant risk factors, whilst 'living with others' appeared to be protective (P < 0.05). Amongst African Americans, on the other hand, old age, rural living below the age of 19 years, low educational attainment and family history of dementia were the risk factors. There was a lack of association between Alzheimer's disease and possession of the apolipoprotein E epsilon4 allele in the Nigerian sample, unlike the finding in African Americans, where significant association was shown. In addition, the frequencies of the vascular risk factors investigated were lower in Nigerians. Our results showed lower prevalence of dementia and Alzheimer's disease in Nigerians, compared with African Americans. There was no association between Alzheimer's disease and apolipoprotein E (epsilon4 allele) in the former. The differences in the frequencies of vascular risk factors between Nigerian subjects and African Americans would suggest involvement of environmental factors in disease process.

Entities:  

Mesh:

Year:  2000        PMID: 11054131     DOI: 10.1046/j.1468-1331.2000.00124.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  29 in total

1.  Generalizability: the trees, the forest, and the low-hanging fruit.

Authors:  Walter A Kukull; Mary Ganguli
Journal:  Neurology       Date:  2012-06-05       Impact factor: 9.910

2.  Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Authors:  K Hall; J Murrell; A Ogunniyi; M Deeg; O Baiyewu; S Gao; O Gureje; J Dickens; R Evans; V Smith-Gamble; F W Unverzagt; J Shen; H Hendrie
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 3.  Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review.

Authors:  Angelique Mavrodaris; John Powell; Margaret Thorogood
Journal:  Bull World Health Organ       Date:  2013-08-20       Impact factor: 9.408

Review 4.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

5.  Cognitive Function in Low-Income and Low-Literacy Settings: Validation of the Tablet-Based Oxford Cognitive Screen in the Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI).

Authors:  Glyn W Humphreys; Mihaela D Duta; Livia Montana; Nele Demeyere; Cathal McCrory; Julia Rohr; Kathleen Kahn; Stephen Tollman; Lisa Berkman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2016-10-21       Impact factor: 4.077

6.  Risk factors for incident Alzheimer's disease in African Americans and Yoruba.

Authors:  A Ogunniyi; K S Hall; O Gureje; O Baiyewu; S Gao; F W Unverzagt; V Smith-Gamble; R E Evans; J Dickens; B S Musick; H C Hendrie
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

Review 7.  Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

Authors:  Paul K Crane; Kaavya Narasimhalu; Laura E Gibbons; Dan M Mungas; Sebastien Haneuse; Eric B Larson; Lewis Kuller; Kathleen Hall; Gerald van Belle
Journal:  J Clin Epidemiol       Date:  2008-05-05       Impact factor: 6.437

Review 8.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 9.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

Review 10.  Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Authors:  Michael Nehls
Journal:  J Mol Psychiatry       Date:  2016-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.